product summary
Loading...
company name :
Bioss
product type :
antibody
product name :
CD105 Polyclonal Antibody
catalog :
bs-4609R
quantity :
100 ul
price :
289.5 USD
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section
more info or order :
citations: 9
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; loading ...; fig s7f
Xie X, Almuzzaini B, Drou N, Kremb S, Yousif A, Farrants A, et al. β-Actin-dependent global chromatin organization and gene expression programs control cellular identity. FASEB J. 2017;: pubmed publisher
  • flow cytometry; rat
Wang Z, Emond Z, Flynn M, Swaminathan S, Kibbe M. Microparticle levels after arterial injury and NO therapy in diabetes. J Surg Res. 2016;200:722-31 pubmed publisher
  • flow cytometry; rat
Wang K, Long Q, Jia C, Liu Y, Yi X, Yang H, et al. Over-expression of Mash1 improves the GABAergic differentiation of bone marrow mesenchymal stem cells in vitro. Brain Res Bull. 2013;99:84-94 pubmed publisher
  • flow cytometry; rat
Gao X, Zhang J, Zhang J, Zou H, Liu J. Identification of rat respiratory mucosa stem cells and comparison of the early neural differentiation potential with the bone marrow mesenchymal stem cells in vitro. Cell Mol Neurobiol. 2014;34:257-68 pubmed publisher
Bidkhori H, Ahmadiankia N, Matin M, Heirani-Tabasi A, Farshchian M, Naderi-Meshkin H, et al. Chemically primed bone-marrow derived mesenchymal stem cells show enhanced expression of chemokine receptors contributed to their migration capability. Iran J Basic Med Sci. 2016;19:14-9 pubmed
Long Q, Qiu B, Wang K, Yang J, Jia C, Xin W, et al. Genetically engineered bone marrow mesenchymal stem cells improve functional outcome in a rat model of epilepsy. Brain Res. 2013;1532:1-13 pubmed publisher
Zhao M, Yin Y, Guo F, Wang J, Wang K, Chen Q. Placental expression of VEGF is increased in pregnancies with hydatidiform mole: possible association with developing very early onset preeclampsia. Early Hum Dev. 2013;89:583-8 pubmed publisher
Gierloff M, Nitsche T, Adam-Klages S, Liebs K, Hedderich J, Gassling V, et al. In vitro comparison of different carrier materials with rat bone marrow MSCs. Clin Oral Investig. 2014;18:247-59 pubmed publisher
Gao Q, Zhao L, Song Z, Yang G. Expression pattern of embryonic stem cell markers in DFAT cells and ADSCs. Mol Biol Rep. 2012;39:5791-804 pubmed publisher
product information
sku :
bs-4609R
name :
CD105 Polyclonal Antibody
category :
Primary Antibody
conjugation :
Unconjugated
host :
Rabbit
target protein :
CD105
modification :
Unmodified
clonality :
Polyclonal
isotype :
IgG
concentration :
1ug/ul
public immunogen range :
60-110/658
subcellular locations :
Extracellular
source :
KLH conjugated synthetic peptide derived from human CD105
gene id link :
Entrez Gene: 2022
swiss prot :
P17813
swiss prot link :
Swiss Prot: P17813
applications :
WB, FCM, IHC-P, IF(IHC-P), IF(ICC)
applications with dilutions :
WB(1:100-1000), FCM(1:20-100), IHC-P(1:100-500), IF(IHC-P)(1:50-200), IF(ICC)(1:50-200)
cross reactive species :
Human, Mouse, Rat
size :
100 ul
price :
289.5 USD
background :
Major glycoprotein of vascular endothelium. Involved in the regulation of angiogenesis. May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors. Acts as TGF-beta coreceptor and is involved in the TGF-beta/BMP signaling cascade. Required for GDF2/BMP9 signaling through SMAD1 in endothelial cells and modulates TGF-beta1 signaling through SMAD3.
purification :
Purified by Protein A.
storage :
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.
synonyms :
END; HHT1; ORW1; Endoglin; CD15; ENG
lead time :
3 to 5 business days.
more info or order :
company information
Bioss
500 West Cummings Park
Suite 6500
Woburn, MA 01801
info@biossusa.com
biossusa.com
800-501-7654
headquarters: USA
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 antigens/primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications. Our company promises fast delivery with strong, top quality scientific support. Bioss Inc is located in the greater Boston area of Massachusetts, the center of the world's largest and fastest growing biotech community.